Advertisement · 728 × 90
#
Hashtag
#RXRX
Advertisement · 728 × 90
Post image



#RXRX #83ea1d8f-fec9-41f5-9d79-0d5b7bf717cb #earningscall-transcripts

Origin | Interest | Match

0 0 0 0
Video

📢 Stocks Trending NOW: #CRCL #FSLR #WDAY #LOW #TJX #PYPL #RXRX #ODD #JOBY #AXON

0 0 0 0
Post image



#FIG #NVDA #RXRX #CRWV #3c9871d8-d7a5-4929-8216-c2c23f7c2717 #investing #Technology #and #Telecom

Origin | Interest | Match

0 0 0 0
How Recursion Used AI to Find a Novel Way to Potentially Treat a Debilitating Rare Disease
How Recursion Used AI to Find a Novel Way to Potentially Treat a Debilitating Rare Disease YouTube video by Recursion

How #Recursion #RXRX Used AI to Find a Novel Way to Potentially Treat a Debilitating Rare #Disease - familial adenomatous polyposis ( #FAP )

youtu.be/faJTWPz8568?...

0 0 0 0
Preview
Biotech Blind Box: GLUE Up 70%, LQDA Lawsuit Looms, Next 2x Bet Market rotation to small caps, Powell probe, moon nukes, AI defense, BTC $95k, biotech blind boxes: how to surf the volatility

Powell probe, CPI miss, tariff silence: small-caps sprint 8% YTD, BTC 95k, GLUE +70% on data, LQDA verdict due, RXRX AI-drug lotto ticket—where’s your next 2x?
#LQDA #BTC #GLUE #RXRX #AI #ClarityAct
open.substack.com/pub/frontier...

0 0 0 0
Most Searched, Monday January 12, 2026 – Crystal Equity Research

Most searched small-cap stocks, Mon Jan 12th - #SATL #LVLU #RXRX #DNN #CLSK #LAC #NVTX #RZLV #RDW #BTBT #BITF #BDSX #PLUG #UAMY #RR #OCUL #HYMC #EVRV #IBRX #ABAT - More: crystalequityresearch.com/most-searche... - #smallcap

0 0 0 0
Most Searched, Wednesday January 7, 2026 – Crystal Equity Research

Most searched small-cap stocks, Wed Jan 7th - #INVX #RXRX #BITF #BBAI #CLSK #LAC #CDIO #UWMC #RR #GLUE #VTYX #MNTS #HOUS #UAMY #ERAS #DNN #CRML #RZLV #NVVE #PLUG - More: crystalequityresearch.com/most-searche... - #smallcap

0 0 0 0
Preview
This Year’s Hottest Healthcare Company Isn’t Even a Healthcare Company - MedCity News Nvidia has quietly become one of the most influential players in healthcare technology by supplying the accelerated computing and AI infrastructure that powers everything from imaging to drug discover...

#Recursion #RXRX $RXRX

The compute enabling #healthcare innovators.

➡️ Read more: medcitynews.com/2025/12/nvid...

@recursionpharma.bsky.social

1 0 0 0
Preview
My Top 20 Holdings in 2026 2026 Top 20 High-Beta Picks for 3x+ Portfolio Growth

2025 portfolio +156% but left cash on the table—can I triple it in 2026 with these 20 high-beta names or will tariffs, Fed drama and AI jitters send me back to square one?
#GOOG #NBIS #Zeta #PATH #TEM #GLUE #RXRX #LQDA #OMDA #LMND #HOOD #TSLA #SYM #TER
open.substack.com/pub/frontier...

0 0 0 0
Most Searched, Tuesday December 30, 2025 – Crystal Equity Research

Most searched small-cap stocks, Tue Dec 30th - #RR #JBLU #RXRX #SLS #BITF #DNN #BTBT #SOPA #BBAI #SIDU #CETX #EKSO #TRON #TLRY #RDW #ONDS #MDXH #HYMC #CERS #BYND - More: crystalequityresearch.com/most-searche... - #smallcap

0 0 0 0
Most Searched, Monday December 29, 2025 – Crystal Equity Research

Most searched small-cap stocks, Mon Dec 29th - #NUAI #GVH #WOK #EXK #RZLV #RARE #SLS #RXRX #RR #PALI #QUBT #PLUG #DBRG #MREO #UUUU #STKE #ONDS #NAK #MARA #ELME - More: crystalequityresearch.com/most-searche... - #smallcap

0 0 0 0

#RXRX #Recursion

0 0 0 0
Most Searched, Tuesday December 23, 2025 – Crystal Equity Research

Most searched small-cap stocks, Tue Dec 23rd - #RDW #CETX #IBRX #RXRX #SIDU #TLRY #UAMY #XRAY #ONDS #HYMC - More: crystalequityresearch.com/most-searche... - #smallcap

0 0 0 0

#Recursion #RXRX

1 0 0 0
Most Searched, Monday December 22, 2025 – Crystal Equity Research

Most searched small-cap stocks, Mon Dec 22nd - #ZIM #PLUG #TE #CMCT #MENS #FJET #AZI #RZLV #CETX #DNN #RXRX #VEDU #SIDU #RDW #PLG #PGEN #MGUY #IPI #HYMC #ABQQD - More: crystalequityresearch.com/most-searche... - #smallcap

0 0 0 0
Most Searched, Wednesday December 17, 2025 – Crystal Equity Research

Most searched small-cap stocks, Wed Dec 17th - #WOLF #QUBT #RR #TE #TWO #IOVA #BTBT #UDMY #DNN #UWMC #BITF #RXLV #RXRX #VTGN #MDLN #BBAI #TLRY #PLUG #PLAB #ONDS - More: crystalequityresearch.com/most-searche... - #smallcap

0 0 0 0
Preview
Recursion Pharmaceuticals Stock Is Soaring Today: Here's Why - Recursion Pharmaceuticals (NASDAQ:RXRX) Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10.

Recursion Pharmaceuticals Stock Is Soaring Today: Here's Why Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutr...

#News #RXRX #why #it's #moving #Movers #RXRX #News #Movers #Benzinga

Origin | Interest | Match

0 0 0 0
Preview
Recursion Pharmaceuticals stock upgraded by JPMorgan on MEK inhibitor potential By Investing.com Recursion Pharmaceuticals stock upgraded by JPMorgan on MEK inhibitor potential

#JPMorgan upgraded #Recursion Pharmaceuticals
(NASDAQ: #RXRX $RXRX )
from Neutral to Overweight on Wednesday

while raising its price target to $11.00 from $10.00.

uk.investing.com/news/analyst...

2 0 0 0
Most Searched, Tuesday December 9, 2025 – Crystal Equity Research

Most searched small-cap stocks, Tue Dec 9th - #RXRX #EXK #NVTS #RR #TROX #XCUR #IRBT #VOR #SNTI #SBET #UUUU #SEI #SANA #PLUG #ONDS #GCT #CLSK #BITF #BBAI - More: crystalequityresearch.com/most-searche... - #smallcap

0 0 0 0
Preview
REC-4881 in FAP: Data Update Webinar YouTube video by Recursion

#Recursion #RXRX $RXRX

REC-4881 in FAP: Data Update #Webinar

www.youtube.com/live/nCj4jE1...

2 0 0 0
Preview
Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks Recursion (NASDAQ: RXRX) reported positive Phase 1b/2 TUPELO results for REC-4881 in familial adenomatous polyposis (FAP) on Dec 8, 2025. REC-4881 (4 mg QD) produced a 43% median polyp-burden reduction at 12 weeks (n=12) with 75% of evaluable patients showing reductions. At Week 25—12 weeks after stopping therapy—82% (9 of 11) maintained reductions with a 53% median decrease from baseline. Safety was consistent with MEK1/2 inhibition: mostly Grade 1–2 TRAEs, 15.8% Grade 3, and no Grade ≥4 reported. Natural-history data showed 87% of similar untreated FAP patients had annualized polyp increases (n=55). Next steps include FDA engagement in 1H26 and population/dosing expansion.

#RXRX Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks

www.stocktitan.net/news/RXRX/positive-phase...

0 0 0 0

#Recursion Pharmaceuticals #RXRX
Virtual Cell

2 0 0 0
Most Searched, Wednesday December 3, 2025 – Crystal Equity Research

Most searched small-cap stocks, Wed Dec 3rd - #RXRX #PMAX #POET #ALIT #BTBT #ABTC #GENI #QCLS #CAPR #SLRX #RR #PLUG #ONDS #KITT #DC #BYND #BTTC #SERV #AEVA - More: crystalequityresearch.com/most-searche... - #smallcap

0 0 0 0
Preview
TedxTribeca 2025 In times of rapid global change, bold ideas shine brightest. These ideas spark hope, resilience and action, because smarter systems and faster algorithms alo...

#Recursion #RXRX

Tonight – Dec. 3, at 7pm ET – tune in to the @TEDx Tribeca livestream and hear from incoming CEO and President Najat Khan, PhD along with other leaders and visionaries addressing the theme “Where innovation meets hope.”

www.youtube.com/live/2zweW8D...

0 0 0 0
Most Searched, Monday December 1, 2025 – Crystal Equity Research

Most searched small-cap stocks, Mon Dec 1st - #CNCK #DNN #EXK #ALIT #ONDS #HIVE #BBWI #FLYE #ZOMDF #WAST #UAVS #TLRY #RLX #NNDM #JANX #IPNFF #GFAI #CLEZ #RXRX #BGM - More: crystalequityresearch.com/most-searche... - #smallcap

0 0 0 0

Here's my list of who could win...

1.) Biotechnology - train scientific foundation models for biology to automate drug/material discovery

Potential winners: #RXRX #DNA #SDGR #ABSI #TWST #ADPT

0 0 1 0
Preview
Recursion Announces Webinar For Upcoming Clinical Data Readout on the TUPELO Phase 1b/2 Trial of REC-4881 in Familial Adenomatous Polyposis on December 8, 2025 Recursion (Nasdaq: RXRX) will host a webinar on December 8, 2025 to present an updated clinical readout from the ongoing TUPELO Phase 1b/2 trial of REC-4881 in familial adenomatous polyposis (FAP).The live webinar is scheduled for 8:00 AM ET / 6:00 AM MT / 1:00 PM GMT and will stream on Recursion's X, LinkedIn, and YouTube channels. The session is titled: Ongoing Phase 1b/2 Trial of the Allosteric MEK1/2 Inhibitor REC-4881 as Monotherapy in Familial Adenomatous Polyposis (FAP): Updated Safety and Efficacy.Presenters include Najat Khan, Ph.D. (incoming CEO and President), David Mauro, M.D., Ph.D., Beth Bruckheimer, Ph.D., Jessica Stout, D.O., and Alfred Cohen, M.D.

#RXRX Recursion Announces Webinar For Upcoming Clinical Data Readout on the TUPELO Phase 1b/2 Trial of REC-4881 in Familial Adenomatous Polyposis on December 8, 2025

www.stocktitan.net/news/RXRX/recursion-anno...

0 0 0 0

#Recursion #RXRX $RXRX

( @bsky.app pls add the $ symbol/hashtag for stocks thanks in advance )

2 0 0 0

#Recursion #RXRX $RXRX

1 0 0 0